Journal
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
Volume 26, Issue 3, Pages 193-198Publisher
KARGER
DOI: 10.1159/000151778
Keywords
Amyloid-beta-binding protein; Brain laterality; Postmortem tissue; Alzheimer disease; Schizophrenia; Multi-infarct dementia
Categories
Funding
- MSMT [1M0517]
- IGA MZCR [NR/9322-3]
Ask authors/readers for more resources
Objective: The multifunctional mitochondrial enzyme 17 beta-hydroxysteroid dehydrogenase type 10 could play a role in the development of Alzheimer disease via its high-affinity binding to amyloid-beta peptides and its overexpression. Methods: We evaluated the specificity of alterations in mRNA/enzyme expression levels in human right and left hippocampi. Results: We observed a trend towards right/left laterality in nondemented nonpsychotic controls; however, the degree of asymmetry was higher for mRNA when compared to enzyme expression levels. In Alzheimer disease and schizophrenia, significant shifts to left/right asymmetry were found and the changes were associated with more marked increases in mRNA/enzyme expression in the left hemisphere. On the other hand, no alterations were observed in people with multi-infarct dementia. Conclusion: Our results support studies reporting an impairment of mitochondria in Alzheimer disease or schizophrenia and a higher vulnerability of the dominant hemisphere to pathological processes. Overexpression of the enzyme could be used to distinguish Alzheimer disease from multi-infarct dementia. Copyright (C) 2008 S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available